AbbVie Inc. / Peer group
| InsiderPie Expert Score | P/E ratio | Net margin | ROA | Net income per employee | |
|---|---|---|---|---|---|
| AbbVie Inc. |
70
/ 100
| ||||
| Amgen Inc. |
56
/ 100
| ||||
| Gilead Sciences, Inc. |
73
/ 100
| ||||
| Bayer AG |
51
/ 100
| ||||
| Kyowa Kirin Co., Ltd. |
50
/ 100
| ||||
| Biogen Inc. |
56
/ 100
| ||||
| Pfizer Inc. |
52
/ 100
| ||||
| Roche Holding AG |
50
/ 100
| ||||
| Santen Pharmaceutical Co., Ltd. |
50
/ 100
| ||||
| Sanofi |
55
/ 100
| ||||
| Eli Lilly and Company |
70
/ 100
| ||||
| Chugai Pharmaceutical Co., Ltd. |
51
/ 100
| ||||
| Johnson & Johnson |
61
/ 100
| ||||
| AstraZeneca PLC |
54
/ 100
| ||||
| Recordati Industria Chimica e Farmaceutica S.p.A. |
51
/ 100
| ||||
| Astellas Pharma Inc. |
51
/ 100
| ||||
| GSK plc |
50
/ 100
| ||||
| Virbac SA |
51
/ 100
| ||||
| Bristol-Myers Squibb Company |
62
/ 100
| ||||
| Grifols, S.A. |
53
/ 100
| ||||
| Daiichi Sankyo Company, Limited |
51
/ 100
| ||||
| Novartis AG |
59
/ 100
|